Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01725165
What this trial is testing

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 85
Early research (Phase 1)Ended earlyNCT03634267
What this trial is testing

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus-Related Cervical CarcinomaStage IB2 Cervical Cancer AJCC v8+14 more
M.D. Anderson Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00368992
What this trial is testing

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+5 more
National Cancer Institute (NCI) 110
Large-scale testing (Phase 3)Study completedNCT00982111
What this trial is testing

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 633
Testing effectiveness (Phase 2)Study completedNCT04553939
What this trial is testing

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

Who this might be right for
Urothelial CarcinomaBladder Cancer
Henan Cancer Hospital 50
Large-scale testing (Phase 3)Study completedNCT01631357
What this trial is testing

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 96
Large-scale testing (Phase 3)Looking for participantsNCT06754644
What this trial is testing

Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC

Who this might be right for
NSCLC
Qilu Pharmaceutical Co., Ltd. 808
Large-scale testing (Phase 3)Study completedNCT00465803
What this trial is testing

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 81
Large-scale testing (Phase 3)Active Not RecruitingNCT01993810
What this trial is testing

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Who this might be right for
Stage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7+3 more
Radiation Therapy Oncology Group 330
Early research (Phase 1)Ended earlyNCT00955942
What this trial is testing

Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Lung CancerRadiation Toxicity
Abramson Cancer Center at Penn Medicine 48
Testing effectiveness (Phase 2)Study completedNCT02659059
What this trial is testing

Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Bristol-Myers Squibb 324
Testing effectiveness (Phase 2)UnknownNCT03349203
What this trial is testing

Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer

Who this might be right for
EGF-R Positive Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT00251927
What this trial is testing

Esomeprazole (NEXIUM) vs. Surgery

Who this might be right for
Gastroesophageal Reflux
AstraZeneca 626
Early research (Phase 1)Ended earlyNCT02097225
What this trial is testing

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Ended earlyNCT01413750
What this trial is testing

Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIA Lung Non-Small Cell Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7Stage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 23
Not applicableNot Yet RecruitingNCT06829641
What this trial is testing

Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC

Who this might be right for
NSCLC Stage IIIB, NSCLC Stage IIIC
West China Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT00061646
What this trial is testing

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Abbott 25
Testing effectiveness (Phase 2)Ended earlyNCT03029611
What this trial is testing

IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery

Who this might be right for
Stage III Fallopian Tube CancerStage III Ovarian CancerStage III Primary Peritoneal Cancer+12 more
University of Washington 11
Testing effectiveness (Phase 2)Ended earlyNCT01871571
What this trial is testing

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the RectumStage IIA Rectal Cancer+5 more
University of Southern California 17
Large-scale testing (Phase 3)Study completedNCT00331864
What this trial is testing

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Novartis 531
Next Page